Now showing items 1-11 of 11
-
Can hepatitis B virus infection predict tuberculosis tretament liver toxicity? Development of a preliminary prediction rule
Castro, L. de et al. | Date Issued: 2010 -
Distal painful peripheral neuropathy associated with erythema induratum of Bazin
Silva, M. T. T. et al. | Date Issued: 2006 -
Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil
Brito, R. C. et al. | Date Issued: 2010 -
Factors associated with tuberculosis treatment delay in patients co-infected with HIV in a high prevalence area in Brazil
Nogueira, B. M. F. et al. | Date Issued: 2018 -
High prevalence of hepatitis B virus infection among tuberculosis patients with and without HIV in Rio de Janeiro, Brazil
Blal, C. A. et al. | Date Issued: 2005 -
Inflammatory paradoxical reaction occurring in tuberculosis patients treated with HAART and rifampicin
Fernandes, G. C. et al. | Date Issued: 2002 -
Poor response to tuberculosis treatment with regimens without rifampicin in immunosuppressed AIDS patients
O'Donnel, M. M. et al. | Date Issued: 2002 -
Safety and effectiveness of HAART in tuberculosis-HIV co-infected patients in Brazil
Santos, A. P. G. dos et al. | Date Issued: 2013 -
SOCS in situ expression in tuberculous lymphadenitis in an endemic area
Nicol, A. F. et al. | Date Issued: 2008 -
The roles of GSTM1 and GSTT1 null genotypes and other predictors in anti-tuberculosis drug-induced liver injury
Monteiro, T. P. et al. | Date Issued: 2012 -
Tuberculosis treatment outcomes and factors associated with each of them in a cohort followed up between 2010 and 2014
Cardoso, M. A. et al. | Date Issued: 2017